Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nakwan N et al. - Bosentan may be a useful adjuvant therapy in neonates with PPHN, providing significant improvement in oxygenation, and thus may be particularly useful in the treatment of PPHN in countries with limited resources.

Related Articles

Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09    Relevance Score: 70%

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/27/09    Relevance Score: 69%

New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09    Relevance Score: 69%

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease
British Journal of Haematology, 10/05/09    Relevance Score: 69%

Successful Treatment of an Adult Patient with an Aortopulmonary Window and Severe Unilateral Pulmonary Hypertension
Congenital Heart Disease, 11/19/09    Relevance Score: 68%

Today in Clinical Pharmacology...keeping you current

Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09

Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address